Early in 1998, Wunderlich et al. (1998) observed that the latent TGF-β1 was commonly and significantly elevated among RCC patients and even higher among those with pyelonephritis, indicating the oncogenetic role of TGF-β in RCC. This evidence concerns the gene TGFB1 and renal cell carcinoma.